Page last updated: 2024-08-21

cyproterone acetate and endothelin-1

cyproterone acetate has been researched along with endothelin-1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Matteis, A; Di Paolo, B; Franco, G; Guidi, A; Revoltella, RP1
Cerquetani, E; Fini, M; Leonardo, F; Onorati, D; Rosano, GM; Rossini, P; Vitale, C1
Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V1

Trials

2 trial(s) available for cyproterone acetate and endothelin-1

ArticleYear
Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
    Maturitas, 2001, Dec-14, Volume: 40, Issue:3

    Topics: Brachial Artery; Coronary Artery Disease; Cross-Over Studies; Cyproterone Acetate; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogens, Conjugated (USP); Female; Forearm; Hormone Replacement Therapy; Humans; Middle Aged; Postmenopause; Progesterone Congeners; Regional Blood Flow; Treatment Outcome

2001
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
    Atherosclerosis, 2008, Volume: 196, Issue:2

    Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome

2008

Other Studies

1 other study(ies) available for cyproterone acetate and endothelin-1

ArticleYear
Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal: an immunohistochemical study.
    Cancer, 2001, May-15, Volume: 91, Issue:10

    Topics: Aged; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Endothelin-1; Goserelin; Humans; Immunoenzyme Techniques; Leuprolide; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Receptors, Androgen; Treatment Outcome

2001